AXGN Axogen, Inc.

NASDAQ
$48.75

Axogen, Inc. (AXGN) is expected to report earnings on January 27, 2027, before the market open. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.3% since its last earnings release on October 28, 2026.

Axogen Beat Consensus Estimates, Raises Guidance
Wednesday, October 28, 2026 · 7:02 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 27
Wednesday · 7:05 AM ET
Earnings Whisper
-
vs ($0.01)
Rev est $83.3M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $49.55

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Axogen, Inc.

Axogen is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.